ATTBF / Abattis Bioceuticals Corp. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Abattis Bioceuticals Corp.
US ˙ OTCPK

Mga Batayang Estadistika
CIK 1515768
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Abattis Bioceuticals Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
December 9, 2016 RW

Abattis Bioceuticals FORM RW DATED DECEMBER 5, 2016

Filed by e3 Filing, Computershare 1-800-973-3274 - Abattis Bioceuticals Corp. - Form RW 104 - 9295 198th Street Langley BC V1M3J9 Tel: 604.336.0881 Email:[email protected] December 5, 2016 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street N.W. Washington, D.C. 20549 Re: Abattis Bioceuticals Corp. ? Registration Statement on Form F-1, Registration No. 333-203701

April 28, 2015 EX-10

CONSULTING AGREEMENT BETWEEN ABATTIS BIOCEUTICALS CORP. AND GEORGES LARAQUE MANAGEMENT INC.

CONSULTING AGREEMENT BETWEEN ABATTIS BIOCEUTICALS CORP. AND GEORGES LARAQUE MANAGEMENT INC. THIS AGREEMENT made as of the 6th day of January 2013. AMONG: ABATTIS BIOCEUTICALS CORP., a corporation incorporated under the laws of the Province of British Columbia and having its registered office at 1000 - 355 Burrard St. Vancouver, BC V6C 15N (The "Company") OF THE FIRST PART AND: GEORGES LARAQUE MANA

April 28, 2015 EX-10

REGISTRATION RIGHTS AGREEMENT

REGISTRATION RIGHTS AGREEMENT Registration Rights Agreement (the "Agreement"), dated as of January 28, 2015, by and between Abattis Bioceuticals Corp.

April 28, 2015 EX-10

SUBLICENSE AGREEMENT

SUBLICENSE AGREEMENT THIS SUBLICENSE AGREEMENT ("AGREEMENT") made and entered as of the last date of execution hereinbelow by each party (the "EFFECTIVE DATE") by and between Abattis Bioceuticals Corp.

April 28, 2015 EX-10

CONSULTING AGREEMENT

CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") is made effective as of the 1st day of February, 2014.

April 28, 2015 EX-10

EX-10

LEASE DATE: December 18th, 2013 TO: PurGenesis We, Animo Wellness Corp. dba: Medical Marijuana Labs Corp., (herein referred to as the "Tenant"), hereby offer to lease from PurGenesis. (herein referred to as the "Landlord"), the following premises forming part of an industrial building bearing civic number 360, rue des Entrepreneurs, Montmagny, Province of Quebec (the "Building") and a list of serv

April 28, 2015 EX-10

AUDIT COMMITTEE CHARTER

AUDIT COMMITTEE CHARTER 1. Mandate The Audit Committee (the "Committee") of the board of directors (the "Board") of Abattis Bioceuticals Corp. (the "Company") is a standing committee of the Board whose primary function is to assist the Board in fulfilling its oversight responsibilities by reviewing (1) the financial statements, reports and other financially-based information provided to shareholde

April 28, 2015 EX-10

- 1 -

THIS INDENTURE OF LEASE made as of November 1, 2012 BETWEEN: TORO HOLDINGS LTD., a company incorporated under the laws of British Columbia, with mailing address at 12440 - 241 Street Maple Ridge, British Columbia V4R 1N3 (the "Landlord") OF THE FIRST PART AND: NORTHERN VINE CANADA INC. (Inc. No. BC0718177), a company incorporated under the laws of British Columbia, with mailing address at 104 - 92

April 28, 2015 EX-10

EXECUTIVE CONSULTING AGREEMENT

EXECUTIVE CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") is made effective as of the 1st day of April, 2014 (the "Effective Date").

April 28, 2015 EX-3

FORM 1 (Section 5)

FORM 1 (Section 5) COMPANY ACT MEMORANDUM I wish to be formed into a Company with limited liability under the Company Act in pursuance of this Memorandum.

April 28, 2015 EX-10

License Agreement TerraSphere Systems, LLC and Biocube Green Grow Systems Corp.,

License Agreement TerraSphere Systems, LLC and Biocube Green Grow Systems Corp., THIS AGREEMENT made and entered into as of the last date of execution hereinbelow (the "Effective Date") by and between TerraSphere Systems, LLC, of 65 Atlantic Avenue, Boston, MA 02110 (hereinafter "TerraSphere") and Biocube Green Grow Systems Corp., a wholly owned subsidiary of Abattis Bioceuticals Corp., having an

April 28, 2015 EX-10

DISTRIBUTION AGREEMENT

DISTRIBUTION AGREEMENT THIS AGREEMENT dated for reference and effect the 20th day of April, 2012.

April 28, 2015 EX-10

Digital Marketing, Branding, and IR Management for Abattis Bioceuticals Corp.

EX-10 20 ex10.14.htm EXHIBIT 10.14 Digital Marketing, Branding, and IR Management for Abattis Bioceuticals Corp. This Service Agreement ("Agreement") is made and entered into this 1st day of April, 2014 ("Effective Date"), by and between Emerging Growth, LLC doing business as TDM Financial ("TDMFinancial" or "TDMF"), having its principal place of business at 913 Wisconsin Ave., Suite 204, Whitefis

April 28, 2015 F-1

OMB APPROVAL

OMB APPROVAL OMB Number: 3235-0258 Expires: December 31, 2017 Estimated average burden hours per response: 1802.

April 28, 2015 EX-10

SHARE EXCHANGE AGREEMENT

SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT is dated as of the 9th day of April, 2014.

April 28, 2015 EX-10

INVESTMENT AGREEMENT

INVESTMENT AGREEMENT INVESTMENT AGREEMENT (this "AGREEMENT"), dated as of January 28, 2015 by and between ABATTIS BIOCEUTICALS CORP.

April 28, 2015 EX-10

SUBLEASE AGREEMENT

SUBLEASE AGREEMENT THIS SUBLEASE AGREEMENT is made as of the 21st day of May 2014 BETWEEN: IJUANA CANNABIS INC.

April 28, 2015 EX-10

CONSULTING AGREEMENT

CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") is made effective as of the tday of t, 2014.

April 28, 2015 EX-10

ABATTIS BIOLOGIX CORPORATION (the "Company") 2012 STOCK OPTION PLAN (the "Plan")

ABATTIS BIOLOGIX CORPORATION (the "Company") 2012 STOCK OPTION PLAN (the "Plan") Dated for Reference June 18, 2012 ARTICLE 1 PURPOSE AND INTERPRETATION Purpose 1.

April 28, 2015 EX-10

AMENDED LICENSE AGREEMENT

AMENDED LICENSE AGREEMENT THIS AGREEMENT ("AGREEMENT") made and entered as of the last date of execution hereinbelow by each party (the "EFFECTIVE DATE") by and between Vertical Designs Ltd ("LICENSOR") a British Columbia corporation with an office at #25 -1833, Coast Meridian St, Port Coquitlam, B.

April 28, 2015 EX-10

CONSULTING AGREEMENT BETWEEN ABATTIS BIOLOGIX CORPORATION AND TERENCE FEALEY

CONSULTING AGREEMENT BETWEEN ABATTIS BIOLOGIX CORPORATION AND TERENCE FEALEY THIS AGREEMENT made as of the 1st day of March 2012.

April 28, 2015 EX-3

BUSINESS CORPORATIONS ACT ABATTIS BIOCEUTICALS CORP. (the "Company") TABLE OF CONTENTS

BUSINESS CORPORATIONS ACT ARTICLES OF ABATTIS BIOCEUTICALS CORP. (the "Company") TABLE OF CONTENTS PART 1 INTERPRETATION 1 PART 2 SHARES AND SHARE CERTIFICATES 2 PART 3 ISSUE OF SHARES 3 PART 4 SHARE REGISTERS 4 PART 5 SHARE TRANSFERS 5 PART 6 TRANSMISSION OF SHARES 6 PART 7 PURCHASE, REDEEM OR OTHERWISE ACQUIRE SHARES 7 PART 8 BORROWING POWERS 8 PART 9 ALTERATIONS 8 PART 10 MEETING OF SHAREHOLDER

April 28, 2015 EX-10

CONSULTING AGREEMENT

CONSULTING AGREEMENT THIS AGREEMENT made effective as of the 28th day of August, 2013.

April 28, 2015 EX-10

AMENDING REGISTRATION RIGHTS AGREEMENT

AMENDING REGISTRATION RIGHTS AGREEMENT THIS AMENDING REGISTRATION RIGHTS AGREEMENT dated for reference April 1, 2015.

April 28, 2015 EX-21

1

List of Subsidiaries of Company Name Jurisdiction of Incorporation Principal Activity % Owned Company Interest Abattis Bioceuticals International Inc.

April 28, 2015 EX-10

EXECUTIVE CONSULTING AGREEMENT Chief Financial Officer, Chief Operating Officer

EXECUTIVE CONSULTING AGREEMENT Chief Financial Officer, Chief Operating Officer THIS AGREEMENT is dated October 1st, 2013.

April 28, 2015 EX-10

CONSULTING AGREEMENT

CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") is made this 16th day of March, 2014 (the "Effective Date").

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista